The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium.

In a reconstituted flow chamber system, preincubation with chemokines can trigger the arrest of rolling monocytes, suggesting that this interaction could help recruit these cells to early atherosclerotic lesions. To date, however, the contribution of endothelium-derived chemokines found in these lesion to monocyte arrests has not been investigated. The endothelium of lesion-prone carotid arteries from apolipoprotein E-deficient (ApoE(-/-)) mice, but not control mice, presents the chemokines KC (mouse GRO-alpha) and JE (mouse monocyte chemoattractant protein-1 [MCP-1]). Arrest of a monocytic cell line or mouse blood monocytes perfused through carotid arteries of ApoE(-/-) mice was reduced by treating with either pertussis toxin, an antagonist of CXCR2, or an antibody to KC, but this process was insensitive to agents that blocked CCR-2 or JE. Conversely, monocyte accumulation more than doubled upon pre-perfusion of the carotid artery with KC but not with mouse MCP-1. Blockade of alpha(4)beta(1) integrin (VLA-4) or vascular cell adhesion molecule-1, but not CD18 or intercellular adhesion molecule-1, almost completely inhibited the arrest of monocytes. We conclude that when presented by early atherosclerotic lesions, KC but not murine MCP-1 triggers VLA-4-dependent monocyte recruitment.

[1]  Mark Tidswell,et al.  Presentation of Integrins on Leukocyte Microvilli: A Role for the Extracellular Domain in Determining Membrane Localization , 1997, The Journal of cell biology.

[2]  T. Springer,et al.  Role of alpha L beta 2 integrin avidity in transendothelial chemotaxis of mononuclear cells. , 1997, Journal of immunology.

[3]  T. Springer,et al.  Sequential regulation of alpha 4 beta 1 and alpha 5 beta 1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis , 1996, The Journal of cell biology.

[4]  T. Schall,et al.  Local expression of inflammatory cytokines in human atherosclerotic plaques. , 1994, Journal of atherosclerosis and thrombosis.

[5]  E. Butcher,et al.  Chemokines and the arrest of lymphocytes rolling under flow conditions. , 1998, Science.

[6]  M. Cybulsky,et al.  Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. , 1999, Circulation research.

[7]  Amnon Peled,et al.  Subsecond Induction of α4 Integrin Clustering by Immobilized Chemokines Stimulates Leukocyte Tethering and Rolling on Endothelial Vascular Cell Adhesion Molecule 1 under Flow Conditions , 2000, The Journal of experimental medicine.

[8]  P. Murphy,et al.  The CXC Chemokines Growth-regulated Oncogene (GRO) α, GROβ, GROγ, Neutrophil-activating Peptide-2, and Epithelial Cell-derived Neutrophil-activating Peptide-78 Are Potent Agonists for the Type B, but Not the Type A, Human Interleukin-8 Receptor* , 1996, The Journal of Biological Chemistry.

[9]  A. Sher,et al.  Analysis of Fractalkine Receptor CX3CR1 Function by Targeted Deletion and Green Fluorescent Protein Reporter Gene Insertion , 2000, Molecular and Cellular Biology.

[10]  P. Murphy,et al.  The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. , 1996, The Journal of biological chemistry.

[11]  K. Ley,et al.  Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. , 1999, Circulation research.

[12]  A. Beaudet,et al.  P-Selectin or Intercellular Adhesion Molecule (Icam)-1 Deficiency Substantially Protects against Atherosclerosis in Apolipoprotein E–Deficient Mice , 2000, The Journal of experimental medicine.

[13]  YuqingHuo,et al.  Role of Vascular Cell Adhesion Molecule-1 and Fibronectin Connecting Segment-1 in Monocyte Rolling and Adhesion on Early Atherosclerotic Lesions , 2000 .

[14]  L. Nencioni,et al.  Mutants of pertussis toxin suitable for vaccine development. , 1989, Science.

[15]  R. Poston,et al.  Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1. , 1994, The American journal of pathology.

[16]  R. Snyderman,et al.  Chemoattractant Receptors Activate Distinct Pathways for Chemotaxis and Secretion , 1999, The Journal of Biological Chemistry.

[17]  R. Ross,et al.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[18]  R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[19]  K. Ley,et al.  RANTES Deposition by Platelets Triggers Monocyte Arrest on Inflamed and Atherosclerotic Endothelium , 2001, Circulation.

[20]  A. Lusis,et al.  Role of the GRO family of chemokines in monocyte adhesion to MM-LDL-stimulated endothelium. , 1994, The Journal of clinical investigation.

[21]  P. Groot,et al.  Chemokines and atherosclerosis. , 1999, Atherosclerosis.

[22]  P. Weber,et al.  Differential immobilization and hierarchical involvement of chemokines in monocyte arrest and transmigration on inflamed endothelium in shear flow , 1999, European journal of immunology.

[23]  R. Ross,et al.  Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[24]  C. Cochrane,et al.  In vivo, in vitro, and molecular aspects of interleukin-8 and the interleukin-8 receptors. , 1996, The Journal of laboratory and clinical medicine.

[25]  Simon A. Jones,et al.  Chemokine Antagonists That Discriminate between Interleukin-8 Receptors , 1997, The Journal of Biological Chemistry.

[26]  T. Kita,et al.  P-selectin and vascular cell adhesion molecule-1 are focally expressed in aortas of hypercholesterolemic rabbits before intimal accumulation of macrophages and T lymphocytes. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[27]  A. Beaudet,et al.  Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[28]  E. Leonard,et al.  Human monocyte chemoattractant protein-1 (MCP-1). , 1990, Immunology today.

[29]  D. Wagner,et al.  Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. , 2000, Circulation.

[30]  W. Pearce,et al.  Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. , 1993, American Journal of Pathology.

[31]  I. Charo,et al.  Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.

[32]  A. Lusis,et al.  Blocking very late antigen-4 integrin decreases leukocyte entry and fatty streak formation in mice fed an atherogenic diet. , 1999, Circulation research.

[33]  J. Gong,et al.  Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues , 1995, Journal of Experimental Medicine.

[34]  B. Rollins,et al.  Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis. Identification of a mutated protein that inhibits MCP-1-mediated monocyte chemotaxis. , 1994, The Journal of biological chemistry.

[35]  E. Leonard,et al.  Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. , 1993, Human pathology.

[36]  P. Huie,et al.  RANTES chemokine expression in transplant-associated accelerated atherosclerosis. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[37]  R. Gerrity The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. , 1981, The American journal of pathology.

[38]  Gerrity Rg The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. , 1981 .

[39]  C. Murdoch,et al.  Chemokine receptors and their role in inflammation and infectious diseases. , 2000, Blood.

[40]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[41]  Volker Herzog,et al.  Establishment of a human cell line (mono mac 6) with characteristics of mature monocytes , 1988, International journal of cancer.

[42]  J. Gong,et al.  An Antagonist of Monocyte Chemoattractant Protein 1 (MCP-1) Inhibits Arthritis in the MRL-lpr Mouse Model , 1997, The Journal of experimental medicine.

[43]  R. Ross,et al.  Cell biology of atherosclerosis. , 1995, Annual review of physiology.

[44]  B. Engelhardt,et al.  Ligand-induced adhesion to activated endothelium and to vascular cell adhesion molecule-1 in lymphocytes transfected with the N-formyl peptide receptor. , 1994, Journal of immunology.

[45]  E. Appella,et al.  Human monocyte chemoattractant protein‐1 (MCP‐1) Full‐length cDNA cloning, expression in mitogen‐stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE , 1989, FEBS letters.

[46]  K. Ley,et al.  Mice lacking two or all three selectins demonstrate overlapping and distinct functions for each selectin. , 1999, Journal of immunology.

[47]  P. Libby,et al.  Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. , 1998, Molecular cell.

[48]  P. Blackmore,et al.  Role of a guanine nucleotide-binding regulatory protein in the hydrolysis of hepatocyte phosphatidylinositol 4,5-bisphosphate by calcium-mobilizing hormones and the control of cell calcium. Studies utilizing aluminum fluoride. , 1985, The Journal of biological chemistry.

[49]  F. Luscinskas,et al.  MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions , 1999, Nature.

[50]  R. Gerrity,et al.  The role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions. , 1981, The American journal of pathology.

[51]  L. F. Kolakowski,et al.  The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization. , 1994, The Journal of biological chemistry.